Steve Lichtman

Stock Analyst at Oppenheimer

(0.54)

# 3,809

Out of 4,711 analysts

2

Total ratings

n/a

Success rate

-2.56%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Steve Lichtman

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Initiates: Outperform	$275	$242.54	+13.38%	1	Dec 17, 2024
	NARI Inari Medical	Initiates: Outperform	$75	$55.45	+35.26%	1	Dec 17, 2024

Penumbra

Dec 17, 2024

Initiates: Outperform

Price Target: $275

Current: $242.54

Upside: +13.38%

Inari Medical

Dec 17, 2024

Initiates: Outperform

Price Target: $75

Current: $55.45

Upside: +35.26%